Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Installed Building Products, Inc.
14.7% sales growth and 33.33% return on equity
Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation, waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors, and other products in the continental United States.
Installed Building Products, Inc.’s sales growth this year is anticipated to be 9.7% and 15.4% for next year.
Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 1.61B for the twelve trailing months.
Installed Building Products, Inc.’s sales growth for the next quarter is 14.7%. The company’s growth estimates for the ongoing quarter and the next is 33.7% and 39.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.33%.
Volatility
Installed Building Products, Inc.’s last day, last week, and last month’s average volatility was a negative 5.91%, a positive 0.89%, and a positive 0.68%, respectively.
Installed Building Products, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.95%, 5.35%, and 4.00%, respectively.
Installed Building Products, Inc.’s Stock Yearly Top and Bottom Value
Installed Building Products, Inc.’s stock is valued at $106.59 at 07:22 EST, way below its 52-week high of $121.67 and way higher than its 52-week low of $29.02.
Installed Building Products, Inc.’s Moving Average
Installed Building Products, Inc.’s worth is above its 50-day moving average of $101.38 and way higher than its 200-day moving average of $93.00.
2. Gilead Sciences, Inc.
10.3% sales growth and 6.46% return on equity
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally.
Gilead Sciences, Inc.’s sales growth this year is anticipated to be 5.6% and a negative 0.4% for next year.
Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 23.15B for the twelve trailing months.
Gilead Sciences, Inc.’s sales growth for the next quarter is 10.3%. The company’s growth estimates for the current quarter and the next is 32.3% and 4.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.46%.
Volatility
Gilead Sciences, Inc.’s last day, last week, and last month’s average volatility was 0.83%, 1.60%, and 0.15%, respectively.
Gilead Sciences, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.44%, 2.69%, and 1.79%, respectively.
Gilead Sciences, Inc.’s Stock Yearly Top and Bottom Value
Gilead Sciences, Inc.’s stock is valued at $63.04 at 07:22 EST, way below its 52-week high of $85.97 and way higher than its 52-week low of $56.56.
Gilead Sciences, Inc.’s Moving Average
Gilead Sciences, Inc.’s worth is higher than its 50-day moving average of $59.74 and under its 200-day moving average of $65.03.
3. Rollins, Inc.
5.7% sales growth and 28.62% return on equity
Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers.
Rollins, Inc.’s sales growth this year is expected to be 6.9% and 6.7% for next year.
Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 2.13B for the twelve trailing months.
Rollins, Inc.’s sales growth for the next quarter is 5.7%. The company’s growth estimates for the ongoing quarter and the next is 18.2% and 22.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.62%.
Volatility
Rollins, Inc.’s last day, last week, and last month’s average volatility was 1.57%, 0.87%, and 0.38%, respectively.
Rollins, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.77%, 3.13%, and 3.15%, respectively.
Rollins, Inc.’s Stock Yearly Top and Bottom Value
Rollins, Inc.’s stock is valued at $40.80 at 07:22 EST, below its 52-week high of $43.00 and way above its 52-week low of $20.48.
Rollins, Inc.’s Moving Average
Rollins, Inc.’s value is higher than its 50-day moving average of $38.50 and way higher than its 200-day moving average of $36.38.
4. Generac Holdlings Inc.
32.9% sales growth and 25.53% return on equity
Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, and other power products for the residential, and light commercial and industrial markets worldwide.
Generac Holdlings Inc.’s sales growth this year is anticipated to be 11.4% and 17.5% for next year.
Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 2.32B for the twelve trailing months.
Generac Holdlings Inc.’s sales growth for the next quarter is 32.9%. The company’s growth estimates for the ongoing quarter and the next is 28.8% and 72.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.53%.
Volatility
Generac Holdlings Inc.’s last day, last week, and last month’s average volatility was 3.33%, 2.17%, and 0.97%, respectively.
Generac Holdlings Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.39%, 4.08%, and 4.09%, respectively.
Generac Holdlings Inc.’s Stock Yearly Top and Bottom Value
Generac Holdlings Inc.’s stock is valued at $252.50 at 07:22 EST, under its 52-week high of $260.00 and way above its 52-week low of $75.50.
Generac Holdlings Inc.’s Moving Average
Generac Holdlings Inc.’s worth is way above its 50-day moving average of $221.44 and way above its 200-day moving average of $187.63.
5. Bridgeline Digital, Inc.
9.6% sales growth and 4.62% return on equity
Bridgeline Digital, Inc. operates as a digital engagement company in the United States.
Bridgeline Digital, Inc.’s sales growth this year is anticipated to be 14.1% and a negative 0% for next year.
Year-on-year quarterly revenue growth grew by 0.6%, now sitting on 10.91M for the twelve trailing months.
Bridgeline Digital, Inc.’s sales growth for the next quarter is 9.6%. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.62%.
Volatility
Bridgeline Digital, Inc.’s last day, last week, and last month’s average volatility was a negative 1.78%, a positive 1.77%, and a negative 0.06%, respectively.
Bridgeline Digital, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.91%, 6.24%, and 8.12%, respectively.
Bridgeline Digital, Inc.’s Stock Yearly Top and Bottom Value
Bridgeline Digital, Inc.’s stock is valued at $2.81 at 07:22 EST, way below its 52-week high of $3.62 and way above its 52-week low of $0.53.
Bridgeline Digital, Inc.’s Moving Average
Bridgeline Digital, Inc.’s worth is above its 50-day moving average of $2.71 and way above its 200-day moving average of $2.25.
6. Systemax Inc.
10.7% sales growth and 35.39% return on equity
Systemax Inc., through its subsidiaries, operates as a direct marketer of brand name and private label industrial and business equipment and supplies in North America.
Systemax Inc.’s sales growth this year is anticipated to be 7% and 5.5% for next year.
Year-on-year quarterly revenue growth grew by 17.1%, now sitting on 977.3M for the twelve trailing months.
Systemax Inc.’s sales growth for the next quarter is 10.7%. The company’s growth estimates for the present quarter and the next is 43.3% and 76.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.39%.
Volatility
Systemax Inc.’s last day, last week, and last month’s average volatility was 1.65%, 1.53%, and 0.31%, respectively.
Systemax Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.44%, 2.43%, and 2.58%, respectively.
Systemax Inc.’s Stock Yearly Top and Bottom Value
Systemax Inc.’s stock is valued at $38.72 at 07:22 EST, below its 52-week high of $38.78 and way higher than its 52-week low of $14.00.
Systemax Inc.’s Moving Average
Systemax Inc.’s worth is way higher than its 50-day moving average of $34.70 and way higher than its 200-day moving average of $25.86.
7. Farmers National Banc Corp.
10.2% sales growth and 12.7% return on equity
Farmers National Banc Corp., a financial holding company, operates in the banking, trust, retirement consulting, insurance, and financial management industries.
Farmers National Banc Corp.’s sales growth this year is expected to be 18.9% and a negative 2.1% for next year.
Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 118.58M for the twelve trailing months.
Farmers National Banc Corp.’s sales growth for the next quarter is 10.2%. The company’s growth estimates for the ongoing quarter and the next is a negative 5.7% and 23.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.7%.
Volatility
Farmers National Banc Corp.’s last day, last week, and last month’s average volatility was a negative 3.09%, a positive 1.00%, and a positive 0.13%, respectively.
Farmers National Banc Corp.’s last day, last week, and last month’s high and low average amplitude percentage was 5.36%, 4.79%, and 3.11%, respectively.
Farmers National Banc Corp.’s Stock Yearly Top and Bottom Value
Farmers National Banc Corp.’s stock is valued at $13.91 at 07:22 EST, way below its 52-week high of $16.47 and way above its 52-week low of $9.82.
Farmers National Banc Corp.’s Moving Average
Farmers National Banc Corp.’s value is higher than its 50-day moving average of $13.38 and way higher than its 200-day moving average of $11.96.
